PTC Therapeutics, Inc.
USD78.50
+0.49 (+0.63%)
CEO
Matthew Klein
IPO Date
2013-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$80.17
Prev. Close
$78.01
Day Low
$77.53
Day High
$80.56
52W Low
$43.17
52W High
$90.87
Market Cap
$6.51B
Volume
1.12M
| 10,000 |
| $42.95 |
| 13 Jul 2026 | Smith Mary L. | director | S-Sale | Disposed | 5,834 | $90.00 |
| 13 Jul 2026 | Smith Mary L. | director | M-Exempt | Acquired | 5,834 | $42.95 |
| 13 Jul 2026 | Smith Mary L. | director | M-Exempt | Disposed | 5,834 | $42.95 |
| 13 Jul 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Acquired | 2,464 | $46.54 |
| 13 Jul 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | S-Sale | Disposed | 2,464 | $90.25 |
| 13 Jul 2026 | Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | M-Exempt | Disposed | 2,464 | $46.54 |
| 8 Jul 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | M-Exempt | Acquired | 2,266 | $39.42 |
| 8 Jul 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | S-Sale | Disposed | 313 | $83.10 |